Isorhamnetin Exerts Antifibrotic Effects by Attenuating Platelet-Derived Growth Factor-BB-induced HSC-T6 Cells Activation via Suppressing PI3K-AKT Signaling Pathway

BACKGROUND: Currently, liver fibrosis is growing worldwide; unfortunately, there is no definite cure for this disease. Hence, understanding the molecular pathways involved in the development of liver fibrosis can help to find a proper treatment. In this study, we aimed to evaluate the effects of iso...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashidi, Mojtaba, Matour, Emad, Beheshti Nasab, Hasti, Cheraghzadeh, Maryam, Shakerian, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pasteur Institute of Iran 2023
Materias:
Full Length
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507286/
https://www.ncbi.nlm.nih.gov/pubmed/37598299
http://dx.doi.org/10.52547/ibj.3948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507286/
https://www.ncbi.nlm.nih.gov/pubmed/37598299
http://dx.doi.org/10.52547/ibj.3948

Ejemplares similares